34427537|t|The protective effects of naproxen against interleukin-1beta (IL-1beta)- induced damage in human umbilical vein endothelial cells (HUVECs).
34427537|a|Non-steroidal anti-inflammatory drugs (NSAIDs) are one of the most widely used medications in the world. Naproxen is an NSAID with relatively low selectivity for cyclooxygenase-2 (COX-2), thereby having decreased risk for cardiovascular (CV) events. However, it is unclear whether naproxen might provide protection against atherosclerosis, an underlying cause of numerous cardiovascular diseases (CVDs). In the present study, we exposed human umbilical vein endothelial cells to interleukin-1beta (IL-1beta), a key cytokine involved in atherogenesis, with or without naproxen. Our findings indicate that naproxen could protect against IL-1beta-induced damage by improving cell viability and preventing cell death. Additionally, naproxen suppressed the expression of the cytokines IL-6, IL-12, and tumor necrosis factor-alpha (TNF-alpha), and downregulated the expression of vascular endothelial growth factor (VEGF) and tissue factor (TF) induced by IL-1beta. Importantly, naproxen also inhibited the attachment of monocytes to endothelial cells, which was achieved through Kruppel-like factor 6 (KLF6)-mediated reduced expression of intracellular adhesion molecule-1 (ICAM-1) and E-selectin. These findings suggest that naproxen may aid in the prevention of atherosclerosis by exerting cardioprotective effects beyond low COX-2-selectivity.
34427537	26	34	naproxen	Chemical	MESH:D009288
34427537	43	60	interleukin-1beta	Gene	3553
34427537	62	70	IL-1beta	Gene	3553
34427537	91	96	human	Species	9606
34427537	245	253	Naproxen	Chemical	MESH:D009288
34427537	302	318	cyclooxygenase-2	Gene	5743
34427537	320	325	COX-2	Gene	5743
34427537	421	429	naproxen	Chemical	MESH:D009288
34427537	463	478	atherosclerosis	Disease	MESH:D050197
34427537	512	535	cardiovascular diseases	Disease	MESH:D002318
34427537	537	541	CVDs	Disease	MESH:D002318
34427537	577	582	human	Species	9606
34427537	619	636	interleukin-1beta	Gene	3553
34427537	638	646	IL-1beta	Gene	3553
34427537	676	689	atherogenesis	Disease	MESH:D050197
34427537	707	715	naproxen	Chemical	MESH:D009288
34427537	744	752	naproxen	Chemical	MESH:D009288
34427537	775	783	IL-1beta	Gene	3553
34427537	868	876	naproxen	Chemical	MESH:D009288
34427537	920	924	IL-6	Gene	3569
34427537	926	931	IL-12	Gene	3593
34427537	937	964	tumor necrosis factor-alpha	Gene	7124
34427537	966	975	TNF-alpha	Gene	7124
34427537	1014	1048	vascular endothelial growth factor	Gene	7422
34427537	1050	1054	VEGF	Gene	7422
34427537	1060	1073	tissue factor	Gene	2152
34427537	1075	1077	TF	Gene	2152
34427537	1090	1098	IL-1beta	Gene	3553
34427537	1113	1121	naproxen	Chemical	MESH:D009288
34427537	1214	1235	Kruppel-like factor 6	Gene	1316
34427537	1237	1241	KLF6	Gene	1316
34427537	1274	1307	intracellular adhesion molecule-1	Gene	3383
34427537	1309	1315	ICAM-1	Gene	3383
34427537	1321	1331	E-selectin	Gene	6401
34427537	1361	1369	naproxen	Chemical	MESH:D009288
34427537	1399	1414	atherosclerosis	Disease	MESH:D050197
34427537	1463	1468	COX-2	Gene	5743
34427537	Negative_Correlation	1316	3383
34427537	Negative_Correlation	MESH:D009288	2152
34427537	Positive_Correlation	2152	3553
34427537	Negative_Correlation	MESH:D009288	MESH:D002318
34427537	Association	MESH:D050197	3553
34427537	Negative_Correlation	MESH:D009288	3383
34427537	Negative_Correlation	MESH:D009288	6401
34427537	Negative_Correlation	MESH:D009288	3593
34427537	Association	MESH:D050197	5743
34427537	Negative_Correlation	MESH:D009288	MESH:D050197
34427537	Negative_Correlation	1316	6401
34427537	Association	MESH:D009288	1316
34427537	Negative_Correlation	MESH:D009288	7422
34427537	Negative_Correlation	MESH:D009288	7124
34427537	Negative_Correlation	MESH:D009288	3553
34427537	Negative_Correlation	MESH:D009288	3569

